Start
Entdecken
nav.journalClub
Trends
Mehr
Synapse
⌘+K
Synapse
Sprache
Deutsch
Deutsch
Early Olfactory Recovery With Tezepelumab in CRSwNP: Mechanistic and Clinical Considerations | Synapse
April 19, 2026
Early Olfactory Recovery With Tezepelumab in CRSwNP: Mechanistic and Clinical Considerations
SK
Sushma Narsing Katkuri
Dr. Reddy's Laboratories (India)
VV
Varshini Vadhithala
Dr. D. Y. Patil Medical College, Hospital and Research Centre
SK
Sachin Kumar
Graphic Era University
See all
Key Points
To explore the mechanisms and clinical impacts of tezepelumab on olfactory recovery in chronic rhinosinusitis with nasal polyps.
Investigated the olfactory recovery process in patients treated with tezepelumab.
Analyzed clinical outcomes related to olfactory function post-treatment.
Early signs of olfactory recovery observed in patients receiving tezepelumab.
Mechanistic insights into how tezepelumab aids in olfactory function restoration.
Abstract
The authors declare no conflicts of interest.
KI fragen
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Katkuri et al. (Fri,) studied this question.
synapsesocial.com/papers/69e472a8010ef96374d8eb2e
https://doi.org/https://doi.org/10.1002/alr.70167
KI fragen
Mark Helpful
Like
Save
Bookmark
Relay
Share